The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Medical Molecular Imaging Market Research Report 2025

Global Medical Molecular Imaging Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1905305

No of Pages : 96

Ask Your Query
Synopsis
The global Medical Molecular Imaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Medical Molecular Imaging is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Medical Molecular Imaging is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Medical Molecular Imaging in Oncology is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Medical Molecular Imaging include Cardiarc, Digirad, Gamma Medica, GE, Gvi Medical Devices, Hitachi, Mediso, CMR Naviscan and Neurologica, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Medical Molecular Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Molecular Imaging.
Report Scope
The Medical Molecular Imaging market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Molecular Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Molecular Imaging companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cardiarc
Digirad
Gamma Medica
GE
Gvi Medical Devices
Hitachi
Mediso
CMR Naviscan
Neurologica
Neusoft
BC Technical
Philips
Positron
Siemens
Biosensors International
Toshiba
Trivitron Healthcare
Molecular Devices
Segment by Type
MRI
CT
PET
SPECT
Ultrasound
Segment by Application
Oncology
Cardio and Vascular
Neurology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Molecular Imaging companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical Molecular Imaging Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 MRI
1.2.3 CT
1.2.4 PET
1.2.5 SPECT
1.2.6 Ultrasound
1.3 Market by Application
1.3.1 Global Medical Molecular Imaging Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardio and Vascular
1.3.4 Neurology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medical Molecular Imaging Market Perspective (2019-2030)
2.2 Medical Molecular Imaging Growth Trends by Region
2.2.1 Global Medical Molecular Imaging Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Medical Molecular Imaging Historic Market Size by Region (2019-2024)
2.2.3 Medical Molecular Imaging Forecasted Market Size by Region (2025-2030)
2.3 Medical Molecular Imaging Market Dynamics
2.3.1 Medical Molecular Imaging Industry Trends
2.3.2 Medical Molecular Imaging Market Drivers
2.3.3 Medical Molecular Imaging Market Challenges
2.3.4 Medical Molecular Imaging Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical Molecular Imaging Players by Revenue
3.1.1 Global Top Medical Molecular Imaging Players by Revenue (2019-2024)
3.1.2 Global Medical Molecular Imaging Revenue Market Share by Players (2019-2024)
3.2 Global Medical Molecular Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medical Molecular Imaging Revenue
3.4 Global Medical Molecular Imaging Market Concentration Ratio
3.4.1 Global Medical Molecular Imaging Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Molecular Imaging Revenue in 2023
3.5 Medical Molecular Imaging Key Players Head office and Area Served
3.6 Key Players Medical Molecular Imaging Product Solution and Service
3.7 Date of Enter into Medical Molecular Imaging Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical Molecular Imaging Breakdown Data by Type
4.1 Global Medical Molecular Imaging Historic Market Size by Type (2019-2024)
4.2 Global Medical Molecular Imaging Forecasted Market Size by Type (2025-2030)
5 Medical Molecular Imaging Breakdown Data by Application
5.1 Global Medical Molecular Imaging Historic Market Size by Application (2019-2024)
5.2 Global Medical Molecular Imaging Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Medical Molecular Imaging Market Size (2019-2030)
6.2 North America Medical Molecular Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Medical Molecular Imaging Market Size by Country (2019-2024)
6.4 North America Medical Molecular Imaging Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medical Molecular Imaging Market Size (2019-2030)
7.2 Europe Medical Molecular Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Medical Molecular Imaging Market Size by Country (2019-2024)
7.4 Europe Medical Molecular Imaging Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical Molecular Imaging Market Size (2019-2030)
8.2 Asia-Pacific Medical Molecular Imaging Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Medical Molecular Imaging Market Size by Region (2019-2024)
8.4 Asia-Pacific Medical Molecular Imaging Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medical Molecular Imaging Market Size (2019-2030)
9.2 Latin America Medical Molecular Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Medical Molecular Imaging Market Size by Country (2019-2024)
9.4 Latin America Medical Molecular Imaging Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical Molecular Imaging Market Size (2019-2030)
10.2 Middle East & Africa Medical Molecular Imaging Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Medical Molecular Imaging Market Size by Country (2019-2024)
10.4 Middle East & Africa Medical Molecular Imaging Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cardiarc
11.1.1 Cardiarc Company Detail
11.1.2 Cardiarc Business Overview
11.1.3 Cardiarc Medical Molecular Imaging Introduction
11.1.4 Cardiarc Revenue in Medical Molecular Imaging Business (2019-2024)
11.1.5 Cardiarc Recent Development
11.2 Digirad
11.2.1 Digirad Company Detail
11.2.2 Digirad Business Overview
11.2.3 Digirad Medical Molecular Imaging Introduction
11.2.4 Digirad Revenue in Medical Molecular Imaging Business (2019-2024)
11.2.5 Digirad Recent Development
11.3 Gamma Medica
11.3.1 Gamma Medica Company Detail
11.3.2 Gamma Medica Business Overview
11.3.3 Gamma Medica Medical Molecular Imaging Introduction
11.3.4 Gamma Medica Revenue in Medical Molecular Imaging Business (2019-2024)
11.3.5 Gamma Medica Recent Development
11.4 GE
11.4.1 GE Company Detail
11.4.2 GE Business Overview
11.4.3 GE Medical Molecular Imaging Introduction
11.4.4 GE Revenue in Medical Molecular Imaging Business (2019-2024)
11.4.5 GE Recent Development
11.5 Gvi Medical Devices
11.5.1 Gvi Medical Devices Company Detail
11.5.2 Gvi Medical Devices Business Overview
11.5.3 Gvi Medical Devices Medical Molecular Imaging Introduction
11.5.4 Gvi Medical Devices Revenue in Medical Molecular Imaging Business (2019-2024)
11.5.5 Gvi Medical Devices Recent Development
11.6 Hitachi
11.6.1 Hitachi Company Detail
11.6.2 Hitachi Business Overview
11.6.3 Hitachi Medical Molecular Imaging Introduction
11.6.4 Hitachi Revenue in Medical Molecular Imaging Business (2019-2024)
11.6.5 Hitachi Recent Development
11.7 Mediso
11.7.1 Mediso Company Detail
11.7.2 Mediso Business Overview
11.7.3 Mediso Medical Molecular Imaging Introduction
11.7.4 Mediso Revenue in Medical Molecular Imaging Business (2019-2024)
11.7.5 Mediso Recent Development
11.8 CMR Naviscan
11.8.1 CMR Naviscan Company Detail
11.8.2 CMR Naviscan Business Overview
11.8.3 CMR Naviscan Medical Molecular Imaging Introduction
11.8.4 CMR Naviscan Revenue in Medical Molecular Imaging Business (2019-2024)
11.8.5 CMR Naviscan Recent Development
11.9 Neurologica
11.9.1 Neurologica Company Detail
11.9.2 Neurologica Business Overview
11.9.3 Neurologica Medical Molecular Imaging Introduction
11.9.4 Neurologica Revenue in Medical Molecular Imaging Business (2019-2024)
11.9.5 Neurologica Recent Development
11.10 Neusoft
11.10.1 Neusoft Company Detail
11.10.2 Neusoft Business Overview
11.10.3 Neusoft Medical Molecular Imaging Introduction
11.10.4 Neusoft Revenue in Medical Molecular Imaging Business (2019-2024)
11.10.5 Neusoft Recent Development
11.11 BC Technical
11.11.1 BC Technical Company Detail
11.11.2 BC Technical Business Overview
11.11.3 BC Technical Medical Molecular Imaging Introduction
11.11.4 BC Technical Revenue in Medical Molecular Imaging Business (2019-2024)
11.11.5 BC Technical Recent Development
11.12 Philips
11.12.1 Philips Company Detail
11.12.2 Philips Business Overview
11.12.3 Philips Medical Molecular Imaging Introduction
11.12.4 Philips Revenue in Medical Molecular Imaging Business (2019-2024)
11.12.5 Philips Recent Development
11.13 Positron
11.13.1 Positron Company Detail
11.13.2 Positron Business Overview
11.13.3 Positron Medical Molecular Imaging Introduction
11.13.4 Positron Revenue in Medical Molecular Imaging Business (2019-2024)
11.13.5 Positron Recent Development
11.14 Siemens
11.14.1 Siemens Company Detail
11.14.2 Siemens Business Overview
11.14.3 Siemens Medical Molecular Imaging Introduction
11.14.4 Siemens Revenue in Medical Molecular Imaging Business (2019-2024)
11.14.5 Siemens Recent Development
11.15 Biosensors International
11.15.1 Biosensors International Company Detail
11.15.2 Biosensors International Business Overview
11.15.3 Biosensors International Medical Molecular Imaging Introduction
11.15.4 Biosensors International Revenue in Medical Molecular Imaging Business (2019-2024)
11.15.5 Biosensors International Recent Development
11.16 Toshiba
11.16.1 Toshiba Company Detail
11.16.2 Toshiba Business Overview
11.16.3 Toshiba Medical Molecular Imaging Introduction
11.16.4 Toshiba Revenue in Medical Molecular Imaging Business (2019-2024)
11.16.5 Toshiba Recent Development
11.17 Trivitron Healthcare
11.17.1 Trivitron Healthcare Company Detail
11.17.2 Trivitron Healthcare Business Overview
11.17.3 Trivitron Healthcare Medical Molecular Imaging Introduction
11.17.4 Trivitron Healthcare Revenue in Medical Molecular Imaging Business (2019-2024)
11.17.5 Trivitron Healthcare Recent Development
11.18 Molecular Devices
11.18.1 Molecular Devices Company Detail
11.18.2 Molecular Devices Business Overview
11.18.3 Molecular Devices Medical Molecular Imaging Introduction
11.18.4 Molecular Devices Revenue in Medical Molecular Imaging Business (2019-2024)
11.18.5 Molecular Devices Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock